Ting Yuan
mTORC2 Signaling: A Path for Pancreatic β Cell's Growth and Function
Yuan, Ting; Lupse, Blaz; Maedler, Kathrin; Ardestani, Amin
Abstract
The mechanistic target of rapamycin (mTOR) signaling pathway is an evolutionary conserved pathway that senses signals from nutrients and growth factors to regulate cell growth, metabolism and survival. mTOR acts in two biochemically and functionally distinct complexes, mTOR complex 1 (mTORC1) and 2 (mTORC2), which differ in terms of regulatory mechanisms, substrate specificity and functional outputs. While mTORC1 signaling has been extensively studied in islet/β-cell biology, recent findings demonstrate a distinct role for mTORC2 in the regulation of pancreatic β-cell function and mass. mTORC2, a key component of the growth factor receptor signaling, is declined in β cells under diabetogenic conditions and in pancreatic islets from patients with type 2 diabetes. β cell-selective mTORC2 inactivation leads to glucose intolerance and acceleration of diabetes as a result of reduced β-cell mass, proliferation and impaired glucose-stimulated insulin secretion. Thereby, many mTORC2 targets, such as AKT, PKC, FOXO1, MST1 and cell cycle regulators, play an important role in β-cell survival and function. This indicates mTORC2 as important pathway for the maintenance of β-cell homeostasis, particularly to sustain proper β-cell compensatory response in the presence of nutrient overload and metabolic demand. This review summarizes recent emerging advances on the contribution of mTORC2 and its associated signaling on the regulation of glucose metabolism and functional β-cell mass under physiological and pathophysiological conditions in type 2 diabetes.
Citation
Yuan, T., Lupse, B., Maedler, K., & Ardestani, A. (2018). mTORC2 Signaling: A Path for Pancreatic β Cell's Growth and Function. Journal of Molecular Biology, 430(7), 904-918. https://doi.org/10.1016/j.jmb.2018.02.013
Journal Article Type | Review |
---|---|
Acceptance Date | Feb 14, 2018 |
Online Publication Date | Feb 23, 2018 |
Publication Date | Mar 30, 2018 |
Deposit Date | Jan 4, 2024 |
Journal | Journal of Molecular Biology |
Print ISSN | 0022-2836 |
Electronic ISSN | 1089-8638 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 430 |
Issue | 7 |
Pages | 904-918 |
DOI | https://doi.org/10.1016/j.jmb.2018.02.013 |
Public URL | https://hull-repository.worktribe.com/output/4461638 |
You might also like
Abnormal acinar–β-cell crosstalk in type 2 diabetes
(2023)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search